Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk

2016 ◽  
Vol 22 (37) ◽  
pp. 5676-5686 ◽  
Author(s):  
Giulia Bruzzone ◽  
Giorgia Corbelli ◽  
Paola Belci ◽  
Annalaura Cremonini ◽  
Aldo Pende ◽  
...  
Keyword(s):  
Residual Risk ◽  
Treat To Target ◽  
Global Risk ◽  
Cholesterol Lowering ◽  
Unresolved Problem ◽  
Lowering Therapy

Prevalence of depression in patients with coronary heart disease (CHD) on cholesterol lowering therapy with pravastatin

2000 ◽  
Vol 151 (1) ◽  
pp. 206
Author(s):  
J. Weyers ◽  
D. Colquhoun ◽  
R. Stewart ◽  
A. Tonkin ◽  
I. Marshener ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cholesterol Lowering ◽  
Lowering Therapy ◽  
Prevalence Of Depression

Need to individualise cholesterol-lowering therapy

Heart ◽  
2019 ◽  
Vol 105 (16) ◽  
pp. 1291-1292 ◽  
Author(s):  
Dieter Lütjohann ◽  
Oliver Weingärtner
Keyword(s):  
Cholesterol Lowering ◽  
Lowering Therapy

scholarly journals The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved

Diabetologia ◽  
1996 ◽  
Vol 39 (3) ◽  
pp. 368-370 ◽  
Author(s):  
R. Bender ◽  
K. S. L. Lam ◽  
I. J. Lauder
Keyword(s):  
Diabetic Nephropathy ◽  
Cholesterol Lowering ◽  
Lowering Therapy
Sign in / Sign up

Export Citation Format

Share Document